EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analgesic and Antidiarrheal Properties of Lappaconitine, Possibly Through Cyclooxygenase and µ‐Opioid Receptor Interaction Pathways: In Vivo and In Silico Studies

Shahid Shah, Arifa Akter, Salehin Sheikh, Razina Rouf, Raihan Chowdhury iD, Jannatul Ferdous, Md Shimul Bhuia iD, Imam Hossain Rakib, Md Zahid Hasan iD, Siddique Akber Ansari, Irfan Aamer Ansari, Muhammad Torequl Islam

Immunity, Inflammation and Disease · 2026-02 · 14 (2)

DOI: 10.1002/iid3.70373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 22.02.2026. Verfasst von Shahid Shah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh. Hauptthemen laut MEDLINE: Antidiarrheals, Analgesics, Diarrhea, Aconitine. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lappaconitine (LAP) is a diterpenoid alkaloid with strong anti‐inflammatory activity. However, there is limited information on its gastroprotective effects. The present study aimed to explore the analgesic and antidiarrheal effects of LAP through in vivo and in silico studies.

Methods

For this, LAP was administered orally to Swiss albino mice at doses of 1 and 4 mg/kg (bw). The analgesic effect was assessed using the acetic acid‐induced writhing test. Simultaneously, antidiarrheal activity was evaluated using the castor oil‐induced diarrheal secretion test in mice. In addition, an in silico molecular docking analysis was conducted to forecast the participation of cyclooxygenases (COXs) and the µ‐opioid receptor.

Results

According to our in vivo findings, LAP and combination therapy (LAP + diclofenac sodium) significantly ( p < 0.05) alleviated the number of writhing episodes in the experimental animals compared to the control group. Furthermore, in the castor oil‐induced diarrhea model, LAP and combination therapy (LAP + loperamide) significantly ( p < 0.05) prolonged the onset time of diarrhea and reduced the number of diarrheal secretions. Besides, the molecular docking study suggested that LAP showed better binding affinity (−8.2 and −7.8 kcal/mol) with COX‐1 and COX‐2 enzymes, respectively. Likewise, LAP exhibited the highest binding score (–9.8 kcal/mol) with the µ‐opioid receptor. Moreover, LAP demonstrated high gastrointestinal absorption with low toxicity.

Conclusion

Therefore, LAP exerts potential analgesic and antidiarrheal effects, as well as synergistic properties with diclofenac sodium and loperamide through the cyclooxygenase and MOR interaction pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntidiarrhealsAnalgesicsDiarrheaAconitineReceptors, Opioid, muAnimalsMiceMolecular Docking SimulationMaleCyclooxygenase 2Disease Models, AnimalLoperamideDiclofenacCastor Oil

Stichwörter der Autor:innen

ADMET propertiesanalgesicantidiarrhealditerpenoid alkaloidlappaconitine

Substanzen

AntidiarrhealsAnalgesicsAconitineReceptors, Opioid, muCyclooxygenase 2LoperamideDiclofenacCastor Oil

Autor:innen und Institutionen

  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Dhaka, Bangladesh.
  • Department of Biotechnology and Genetic Engineering, Gopalganj Science and Technology University, Gopalganj, Bangladesh.
  • Department of Chemistry, University of Rajshahi, Rajshahi, Bangladesh.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Departmentof Drug Science and Technology, Universityof Turin, Turin, Italy.

ORCID-Profile: Raihan Chowdhury, Md Shimul Bhuia, Md Zahid Hasan

Zitieren

APA

Shah, S., Akter, A., Sheikh, S., Rouf, R., Chowdhury, R., Ferdous, J., Bhuia, M. S., Rakib, I. H., Hasan, M. Z., Ansari, S. A., Ansari, I. A., & Islam, M. T. (2026). Analgesic and Antidiarrheal Properties of Lappaconitine, Possibly Through Cyclooxygenase and µ‐Opioid Receptor Interaction Pathways: In Vivo and In Silico Studies. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70373

Vancouver

Shah S, Akter A, Sheikh S, Rouf R, Chowdhury R, Ferdous J, et al. Analgesic and Antidiarrheal Properties of Lappaconitine, Possibly Through Cyclooxygenase and µ‐Opioid Receptor Interaction Pathways: In Vivo and In Silico Studies. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70373

BibTeX
@article{Shah2026,
  author = {Shah, Shahid and Akter, Arifa and Sheikh, Salehin and Rouf, Razina and Chowdhury, Raihan and Ferdous, Jannatul and Bhuia, Md Shimul and Rakib, Imam Hossain and Hasan, Md Zahid and Ansari, Siddique Akber and Ansari, Irfan Aamer and Islam, Muhammad Torequl},
  title = {Analgesic and Antidiarrheal Properties of Lappaconitine, Possibly Through Cyclooxygenase and µ‐Opioid Receptor Interaction Pathways: In Vivo and In Silico Studies},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/iid3.70373}
}
Kostenlos starten →